118
H.-K. Luo et al. / Journal of Molecular Catalysis A: Chemical 261 (2007) 112–119
0.25 mmol 2,3-dimethyl-1-butene. Pure product was obtained
by column chromatography over silica gel eluted with hex-
ane/ethyl acetate (9:1). The obtained product was checked with
1H-NMR and 13C-NMR(CDCl3, 400 MHz), which is consistent
with the reported results. Enantiomeric excess was determined
by HPLC with a Chiralcel OD-H column (0.8% 2-propanol in
hexane, flow 1.0 mL/min, (S)enantiomer RT = 27.5 min(major),
(R)enantiomer RT = 58.6 min(minor)).
hexane, flow 1.0 mL/min, (S)enantiomer RT = 8.3 min(major),
(R)enantiomer RT = 11.2 min(minor)).
4.9. Preparation of 4-isopropyl-2-hydroxy-1-
(4-methylphenyl)-4-penten-1-one (2b)
The title compound was prepared according to the general
procedure using 0.25 mmol 4-methylphenylglyoxal monohy-
drate and 0.25 mmol 2,3-dimethyl-1-butene. Pure product was
obtained by column chromatography over silica gel eluted
with hexane/ethyl acetate (9:1). 1H-NMR(CDCl3, 400 MHz,
δ): 1.020, 1.029(d), 1.037, 1.046(d) (–CH3, 6H), 2.161,
2.184, 2.199, 2.222(dd, –CH2CH(OH)–, 1H), 2.282–2.350(m,
–CH(CH3)2, 1H), 2.433(S, Ph-CH3, 3H), 2.585, 2.591, 2.623,
2.629(dd, –CH2CH(OH)–, 1H), 3.687, 3.704(d, –OH, 1H),
4.901, 4.936(s, s, –C CH2, 2H), 5.169–5.216(m, –CH(OH)–,
1H), 7.292, 7.312(d), 7.817, 7.838(d) (Ph-H, 4H). 13C-
NMR(CDCl3, 400 MHz, δ): 21.56, 21.78, 33.57, 41.14, 72.16,
109.63, 128.69, 129.40, 129.59, 131.13, 145.01, 151.37, 201.28.
C15H20O2 (232.33): Calcd. C 77.55%, H 8.68%; found C
77.22%, H 8.97%. Enantiomeric excess was determined by
HPLC with a Chiralcel OD-H column (1.0% 2-propanol in
hexane, flow 1.0 mL/min, (S)enantiomer RT = 7.2 min(major),
(R)enantiomer RT = 9.5 min(minor)).
4.6. Preparation of 6,6-dimethyl-2-hydroxy-4-methylene-1-
phenylheptan-1-one (1c)
The title compound was prepared according to the gen-
eral procedure using 0.25 mmol phenylglyoxal monohydrate
and 0.25 mmol 2,4,4-trimethyl-1-pentene. Pure product was
obtained by column chromatography over silica gel eluted
with hexane/ethyl acetate (9:1). The obtained product was
checked with 1H-NMR and 13C-NMR(CDCl3, 400 MHz),
which is consistent with the reported results. Enantiomeric
excess was determined by HPLC with a Chiralcel OD-H column
(1.0% 2-propanol in hexane, flow 1.0 mL/min, (S)enantiomer
RT = 10.2 min(major), (R)enantiomer RT = 14.3 min(minor)).
4.7. Preparation of 1,4-diphenyl-2-hydroxy-4-
penten-1-one (1d).
4.10. Preparation of 6,6-dimethyl-2-
hydroxy-4-methylene-1-(4-methylphenyl)-heptan-1-one (2c)
The title compound was prepared according to the gen-
eral procedure using 0.25 mmol phenylglyoxal monohydrate
and 0.25 mmol alpha-methylsyrene. Pure product was obtained
by column chromatography over silica gel eluted with hex-
ane/ethyl acetate (9:1). The obtained product was checked with
1H-NMR and 13C-NMR(CDCl3, 400 MHz), which is consistent
with the reported results. Enantiomeric excess was determined
by HPLC with a Chiralcel OB-H column (3.0% 2-propanol in
hexane, flow 1.0 mL/min, (R)enantiomer RT = 20.5 min(minor),
(S)enantiomer RT = 27.4 min(major)).
The title compound was prepared according to the gen-
eral procedure using 0.25 mmol 4-methylphenylglyoxal mono-
hydrate and 0.25 mmol 2,4,4-trimethyl-1-pentene. Pure prod-
uct was obtained by column chromatography over silica
1
gel eluted with hexane/ethyl acetate (9:1). H-NMR(CDCl3,
400 MHz, δ): 0.882(s, –C(CH3)3, 9H), 1.963, 1.996, 2.016,
2.049(q, –CH2C(CH3)3, 2H), 2.197, 2.219, 2.234, 2.256(dd,
–CH2CH(OH)–, 1H), 2.434(s, Ph-CH3, 3H), 2.599, 2.606,
2.636, 2.642(dd, –CH2CH(OH)–, 1H), 3.676, 3.693(d, –OH,
1H), 4.868, 5.012(s, s, –C CH2, 2H), 5.154–5.200(m,
–CH(OH)–, 1H), 7.290, 7.310(d) and 7.818, 7.839(d) (Ph-
H, 4H). 13C-NMR(CDCl3, 400 MHz, δ): 21.76, 29.88, 31.61,
44.24, 49.49, 72.44, 116.31, 128.70, 129.56, 131.14, 143.05,
145.02, 201.20. C17H24O2 (260.38):Calcd. C78.42%, H9.29%;
found C 78.76%, H 9.11%. Enantiomeric excess was determined
by HPLC with a Chiralcel OD-H column (1.0% 2-propanol in
hexane, flow 1.0 mL/min, (S)enantiomer RT = 6.1 min(major),
(R)enantiomer RT = 8.0 min(minor)).
4.8. Preparation of 3-(1ꢀ-cyclohexenyl)-
2-hydroxy-1-(4-methylphenyl)-propan-1-one (2a)
The title compound was prepared according to the gen-
eral procedure using 0.25 mmol 4-methylphenylglyoxal mono-
hydrate and 0.25 mmol methylenecyclohexane. Pure product
was obtained by column chromatography over silica gel eluted
with hexane/ethyl acetate (9:1). 1H-NMR(CDCl3, 400 MHz,
δ): 1.532–1.587(m) and 1.602–1.639(m) (–CH2CH2–, 4H),
2.036–2.042(m, –CH2–C C–, 4H), 2.110, 2.131, 2.146,
2.167(dd, –CH2CH(OH)–, 1H), 2.430(S, Ph-CH3, 3H), 2.459,
2.495(d, –CH2CH(OH)–, 1H), 3.660, 3.677(d, –OH, 1H),
5.133–5.179(m, –CH(OH)–, 1H), 5.475(s, –C CH–, 1H), 7.283,
7.303(d) and 7.806, 7.826(d)(Ph-H, 4H). 13C-NMR(CDCl3,
400 MHz, δ): 21.74, 22.16, 22.83, 25.28, 28.79, 44.66, 72.03,
124.89, 128.72, 129.51, 131.33, 133.36, 144.87, 201.54.
C16H20O2 (244.34): Calcd. C 78.65%, H 8.25%; found C
78.24%, H 8.06%. Enantiomeric excess was determined by
HPLC with a Chiralcel OD-H column (1.0% 2-propanol in
4.11. Preparation of 4-phenyl-1-
(4-methylphenyl)-2-hydroxy-4-penten-1-one (2d)
The title compound was prepared according to the gen-
eral procedure using 0.25 mmol 4-methylphenylglyoxal
monohydrate and 0.25 mmol alpha-methylsyrene. Pure
product was obtained by column chromatography over
silica gel eluted with hexane/ethyl acetate (9:1). 1H-
NMR(CDCl3, 400 MHz, δ): 2.419(s, Ph-CH3, 3H), 2.605,
2.626, 2.641, 2.663(dd, –CH2CH(OH)–, 1H), 3.046, 3.053,